The new guiding rules present suggestions for treating motion signs, referred to as motor signs, in individuals with early Parkinson’s illness.
Moreover, it’s an up to date suggestion on dopaminergic drugs (printed within the 2002 AAN guideline on the initiation of remedy for Parkinson’s illness).
“We carefully reviewed the available research on the effectiveness and possible risks of medications to treat motor symptoms in people with early Parkinson’s disease and found that levodopa is usually the best first treatment for these symptoms. Still, there are side effects with levodopa as well as other drugs, so it is important that a person newly diagnosed with Parkinson’s disease discusses all options with their neurologist before deciding on the best treatment plan for them,” says guideline lead writer Tamara Pringsheim, MD, MSc, of the University of Calgary in Alberta, Canada, and a Fellow of the American Academy of Neurology.
According to the rule of thumb suggestions, remedy with levodopa supplies superior profit at lowering motor signs when in comparison with remedy with both dopamine agonists or MAO-B inhibitors.
These pointers could thus assist alleviate motor signs in PD via applicable drugs.